A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Enovis Corp stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 19,721 shares of ENOV stock, worth $591,432. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,721
Previous 13,758 43.34%
Holding current value
$591,432
Previous $431,000 38.75%
% of portfolio
0.01%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$25.74 - $35.94 $153,487 - $214,310
5,963 Added 43.34%
19,721 $598,000
Q2 2025

Aug 13, 2025

BUY
$29.65 - $37.35 $110,891 - $139,689
3,740 Added 37.33%
13,758 $431,000
Q1 2025

May 14, 2025

BUY
$35.51 - $47.99 $42,256 - $57,108
1,190 Added 13.48%
10,018 $382,000
Q4 2024

Feb 13, 2025

BUY
$38.5 - $49.33 $31,146 - $39,907
809 Added 10.09%
8,828 $387,000
Q3 2024

Nov 14, 2024

SELL
$40.57 - $48.1 $4,949 - $5,868
-122 Reduced 1.5%
8,019 $345,000
Q2 2024

Aug 13, 2024

BUY
$44.56 - $62.43 $5,302 - $7,429
119 Added 1.48%
8,141 $367,000
Q1 2024

May 14, 2024

SELL
$55.44 - $63.8 $19,459 - $22,393
-351 Reduced 4.19%
8,022 $500,000
Q3 2023

Nov 08, 2023

SELL
$51.65 - $65.54 $5,733 - $7,274
-111 Reduced 1.31%
8,373 $441,000
Q2 2023

Aug 10, 2023

SELL
$52.7 - $64.12 $685 - $833
-13 Reduced 0.15%
8,484 $543,000
Q1 2023

May 12, 2023

SELL
$49.5 - $65.92 $1,287 - $1,713
-26 Reduced 0.31%
8,497 $454,000
Q4 2022

Feb 13, 2023

BUY
$44.83 - $57.43 $11,924 - $15,276
266 Added 3.22%
8,523 $456,000
Q3 2022

Nov 10, 2022

SELL
$46.07 - $60.1 $92,140 - $120,200
-2,000 Reduced 19.5%
8,257 $380,000
Q2 2022

Aug 12, 2022

BUY
$55.0 - $70.47 $564,135 - $722,810
10,257 New
10,257 $564,000

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $1.62B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track Mario Gabelli's Portfolio

Track Mario Gabelli Portfolio

Follow Mario Gabelli (Gamco Investors, Inc. Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.